About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

A new study compares body mass index (BMI) with body fat percentage and finds the latter is far more reliable in predicting ...

HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...

Rhythm Pharmaceuticals is advancing its oral obesity drug bivamelagon to Phase III studies after it significantly reduced body mass index (BMI) in all three doses.

A prospective cohort study found that stratifying BMI categories by BMI-specific waist circumference thresholds modestly ...

Paternal obesity was associated with rapid BMI growth trajectories among offspring, especially in the presence of maternal obesity.

Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.

Rhythm said results of the recent trial were also consistent with BMI reductions achieved with setmelanotide therapy in similar patient populations in past trials. Setmelanotide, an existing ...

A new study reports that measurements that detect body fat are a more accurate predictor of mortality risk than body mass ...

A WHO-backed study reveals that overweight postmenopausal women with heart disease face a 31 per cent higher breast cancer ...

Sarcopenic obesity, a hidden condition affecting people over 40, causes muscle loss and fat gain without major weight changes ...

This precision in risk prediction allows for targeted interventions, potentially reducing unnecessary treatments and improving clinical outcomes.